pricing Archives -

June 7, 2022, Washington DC – Fishawack Health (FH) announces the acquisition of leading healthcare consulting and advisory

Data-driven policy and market access firm Avalere joins Fishawack Health

https://pharmaphorum.com/partner-content/data-driven-policy-and-market-access-firm-avalere-joins-fishawack-health/

Equity_World_Access_Map_1140x675_CountryList

Market Access/ News/ News/ News/ Sales and Marketing

Pfizer makes non-profit pledge for low-income nations

Phil Taylor Comirnaty, developing world, market access, Paxlovid, Pfizer, pricing 0 Comment

US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to

Pfizer makes non-profit pledge for low-income nations

https://pharmaphorum.com/news/pfizer-makes-non-profit-pledge-for-low-income-nations/

News/ News/ Sales and Marketing

Civica plans shake-up of insulin sector with low-cost biosimilars

Phil Taylor biosimilar, Civica, Eli Lilly, insulin, Novo Nordisk, pricing, Sanofi 0 Comment

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US

Civica plans shake-up of insulin sector with low-cost biosimilars

https://pharmaphorum.com/news/civica-plans-shake-up-of-insulin-sector-with-low-cost-biosimilars/

Composite image of PAI executive committee

Market Access/ Partner content/ Press releases

Fishawack Health acquires HEOR consultancy PAI

Jack Reinsfield Health economics, HEOR, market access, pricing, Real World Evidence

Fishawack Health expands its VEA capabilities

Fishawack Health acquires HEOR consultancy PAI

https://pharmaphorum.com/partner-content/fishawack-health-acquires-heor-consultancy-pai/

Great Britain £50 - fifty pounds sterling notes spead out.

News/ News/ Sales and Marketing

Drugmakers fined for colluding on NHS price of nausea drug

Phil Taylor competition, NHS, pricing, regulatory, UK 0 Comment

The UK Competition and Markets Authority has ruled that several drugmakers worked together to raise the NHS price

Drugmakers fined for colluding on NHS price of nausea drug

https://pharmaphorum.com/news/drugmakers-fined-for-colluding-on-nhs-price-of-sickness-drug/

News/ News/ Sales and Marketing

Billionaire Mark Cuban steps up assault on US medicine prices

Phil Taylor Mark Cuban Cost Plus Drug Company, Online pharmacy, pharmacy benefit manager, pricing 0 Comment

Mark Cuban, billionaire owner of the Dallas Mavericks basketball team, just got involved in the online pharmacy business,

Billionaire Mark Cuban steps up assault on US medicine prices

https://pharmaphorum.com/news/billionaire-mark-cuban-steps-up-assault-on-us-medicine-prices/

News/ News/ News

Jailed pharma exec fined £47m and banned from industry

Joy Persaud Drug pricing, fraud, Martin Shkreli, pharma, pricing, Vyera Pharmaceuticals 0 Comment

The man who sent the price of lifesaving drug Daraprim (pyrimethamine) rocketing from $13.50 a tablet to $750

Jailed pharma exec fined £47m and banned from industry

https://pharmaphorum.com/news/jailed-pharma-exec-fined-47m-banned-industry/

News/ News/ Sales and Marketing

AbbVie prices first presbyopia drug Vuity at $80 per month

Phil Taylor AbbVie, Allergan, ophthalmology, presbyopia, pricing, Vuity 0 Comment

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight

AbbVie prices first presbyopia drug Vuity at $80 per month

https://pharmaphorum.com/news/abbvie-prices-first-presbyopia-drug-vuity-at-80-per-month/

News/ News/ Sales and Marketing

AbbVie’s Humira tops ICER’s list of unwarranted price hikes again

Phil Taylor AbbVie, Biogen, Humira, ICER, medicines spending, Novartis, pricing, Promacta, Tysabri, US 0 Comment

With drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and

AbbVie’s Humira tops ICER’s list of unwarranted price hikes again

https://pharmaphorum.com/news/abbvies-humira-tops-icers-list-of-unwarranted-price-hikes-again/

Trending

pricing

Login